Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    Why this Ivy League Professor Sees Dow Hitting 18,000

    Chart up exponential

    The bears predicting a stock market crash have it all wrong.

    So says Jeremy Siegel, finance professor at the University of Pennsylvania's Wharton School and author of "Stocks for the Long Run." He predicts the Dow - which closed yesterday (Wednesday) at a new record high 14,455.28 - will continue the bull market run, ending this year in the 16,000 to 17,000 range.

    For 2014, he says, the "best bet goal" is the Dow will climb to 18,000.

    And the well-known bull has nearly 150 years of data to back up his bold prediction.

    Here's why Siegel is so bullish.  

    To continue reading, please click here...


    Read More...
  • stock market charts